Çiğdem Usul Afşar
-
- Cancer Diagnosis and Treatment 5
- Bone health and treatments 4
- Cancer Immunotherapy and Biomarkers 4
-
- Cancer, Hypoxia, and Metabolism 6
-
- Psoriasis: Treatment and Pathogenesis 3
-
- Lymphoma Diagnosis and Treatment 5
-
- Gastric Cancer Management and Outcomes 3
-
- Adrenal and Paraganglionic Tumors 3
- Co-authors
- Meral GünaldıMehmet KarabulutSenem KarabulutBerna Bozkurt Dumanİsmail Oğuz KaraSemra PaydaşBerksoy ŞahinHalil Alış
- Cited by
- OncologyCancer ResearchMicrobiology
- Journals
- Pharmacology (2 papers)Journal of Clinical Oncology (2 papers)Clinical & Translational Oncology (1 paper)
- Partner nations
- TürkiyeAntigua and BarbudaUnited States
In The Last Decade
Çiğdem Usul Afşar
46 papers receiving 428 citations
Peers
Comparison fields: 5 of 80
- Oncology 178
- Cancer Research 63
- Microbiology 3
- Immunology 68
- Cardiology and Cardiovascular Medicine 67
Countries citing papers authored by Çiğdem Usul Afşar
This map shows the geographic impact of Çiğdem Usul Afşar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Çiğdem Usul Afşar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Çiğdem Usul Afşar more than expected).
Fields of papers citing papers by Çiğdem Usul Afşar
This network shows the impact of papers produced by Çiğdem Usul Afşar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Çiğdem Usul Afşar. The network helps show where Çiğdem Usul Afşar may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Çiğdem Usul Afşar, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 0 | |
| 3 | 2023 | 2 | |
| 4 | 2020 | 2 | |
| 5 | 2020 | 6 | |
| 6 | Clinical significance of serum interleukin-17 levels in colorectal cancer patients. | 2017 | 7 |
| 7 | 2017 | 2 | |
| 8 | 2016 | 1 | |
| 9 | 2016 | 8 | |
| 10 | 2015 | 8 | |
| 11 | 2015 | 24 | |
| 12 | 2015 | 12 | |
| 13 | 2014 | 1 | |
| 14 | 2014 | 3 | |
| 15 | 2014 | 3 | |
| 16 | 2014 | 18 | |
| 17 | 2013 | 4 | |
| 18 | 2012 | 13 | |
| 19 | 2012 | 18 | |
| 20 | 2012 | 7 |
About Çiğdem Usul Afşar
Çiğdem Usul Afşar is a scholar working on Microbiology, Oncology and Cancer Research, having authored 50 papers that have together received 438 indexed citations. Recurring topics across this work include Cancer, Hypoxia, and Metabolism (6 papers), Cancer Diagnosis and Treatment (5 papers), Lymphoma Diagnosis and Treatment (5 papers), Bone health and treatments (4 papers), Cancer Immunotherapy and Biomarkers (4 papers), Psoriasis: Treatment and Pathogenesis (3 papers), Gastric Cancer Management and Outcomes (3 papers) and Adrenal and Paraganglionic Tumors (3 papers). The work is most often cited by research in Oncology (178 citations), Cancer Research (63 citations) and Microbiology (3 citations). Çiğdem Usul Afşar has collaborated with scholars based in Türkiye, Antigua and Barbuda and United States. Frequent co-authors include Meral Günaldı, Mehmet Karabulut, Senem Karabulut, Berna Bozkurt Duman, İsmail Oğuz Kara, Semra Paydaş, Berksoy Şahin, Halil Alış, Nuri Faruk Aykan and Murat Serilmez. Their work appears in journals such as Pharmacology, Journal of Clinical Oncology, Clinical & Translational Oncology, Cancer Research and Treatment and Clinical and investigative medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.